STOCK TITAN

Varex Imaging (NASDAQ: VREX) awards 17,094 RSUs to Chief Legal Officer

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Varex Imaging Corp reported that its Chief Legal Officer received an equity award of 17,094 restricted stock units, each converting into one share of common stock. The award is reported as a Form 4 transaction dated December 10, 2025.

These restricted stock units are scheduled to vest in two equal installments, with 50% vesting on December 10, 2027 and the remaining 50% on December 10, 2029. On each vesting date, the underlying common shares will be delivered to the officer, providing long-term stock-based compensation tied to the company’s future performance.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Martinez Matthew Aaron

(Last) (First) (Middle)
1678 S PIONEER RD

(Street)
SALT LAKE CITY UT 84104

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 12/10/2025 A 17,094 (2) (2) Common Stock 17,094 $0 17,094 D
Explanation of Responses:
1. Each Restricted Stock Unit converts into common stock on a one-for-one basis.
2. These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.
Remarks:
/s/ Matthew A. Martinez 12/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Varex Imaging Corp (VREX) report in this Form 4?

The company reported that its Chief Legal Officer received an equity grant of 17,094 restricted stock units on December 10, 2025, as disclosed in Table II of the filing.

How many restricted stock units were granted to the VREX Chief Legal Officer and what do they convert into?

The officer was granted 17,094 restricted stock units. Each restricted stock unit converts into one share of common stock, according to the explanation of responses.

What are the vesting terms of the 17,094 restricted stock units reported by Varex Imaging (VREX)?

The restricted stock units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person on each vest date.

Did the VREX Chief Legal Officer pay a purchase price for the restricted stock units?

No purchase price was paid for the award. The filing lists the price of the derivative security as $0 for the 17,094 restricted stock units.

How is ownership of the granted restricted stock units reported in the VREX Form 4?

The Form 4 shows that 17,094 restricted stock units are beneficially owned following the reported transaction and that the ownership form is reported as Direct (D).

Varex Imaging Corp

NASDAQ:VREX

VREX Rankings

VREX Latest News

VREX Latest SEC Filings

VREX Stock Data

496.52M
40.94M
1.66%
95.51%
2.25%
Medical Devices
Electronic Components, Nec
Link
United States
SALT LAKE CITY